BACKGROUND: Osteoarthritis is a common cause of disability in our community, particularly in the elderly. OBJECTIVE: The aim of treatment in those with osteoarthritis should be the relief of pain and maintenance of function with minimal risk of side effects. DISCUSSION: Non pharmacological therapy, tailored to the individual, should be the first line treatment of osteoarthritis patients. Paracetamol may be added if necessary. Non steroidal anti-inflammatory drugs should only be used after assessing the patient for the risk of side effects. If the risk is high then alternative therapy should be sought, or measures taken to minimise the risk
Paracetamol is the first choice mediation for osteoarthritis. The analgetic potential of NSAIDs is s...
Osteoarthritis (OA) is a debilitative, painful condition with significant global burden. Pharmacolog...
Abstract: Current treatment guidelines for the treatment of chronic pain associated with osteoarthri...
Osteoarthritis is a common cause of disability in the elderly. Management involves pharmacological a...
Non-pharmacological interventions are the first-line therapy for osteoarthritis. If non-pharmacologi...
Osteoarthritis is a common cause of disability in the elderly. Management involves pharmacological a...
The paper presents the results of the Osteoarthritis (OA) Expert Council held on September 8, 2019, ...
Osteoarthritis (OA) is the most common pathology of the musculoskeletal system and is a serious medi...
Goal of osteoarthritis (OA) treatment is to relieve the pain and to reduce the loss of patient's phy...
Osteoarthritis (OA) is a leading cause of disability among older adults worldwide. Treatment aims ar...
Osteoarthritis is a chronic condition involving degeneration of cartilage within the joints. It is t...
Osteoarthritis (OA) is currently defined by the American College of Rheumatology as a "heterogeneous...
Osteoarthritis (OA) is currently defined by the American College of Rheumatology as a "heterogeneous...
Osteoarthritis (OA) is the most common form of joint disease and the leading cause of pain and physi...
Osteoarthritis is an arthritic condition of the joints commonly found in the elderly population. Thi...
Paracetamol is the first choice mediation for osteoarthritis. The analgetic potential of NSAIDs is s...
Osteoarthritis (OA) is a debilitative, painful condition with significant global burden. Pharmacolog...
Abstract: Current treatment guidelines for the treatment of chronic pain associated with osteoarthri...
Osteoarthritis is a common cause of disability in the elderly. Management involves pharmacological a...
Non-pharmacological interventions are the first-line therapy for osteoarthritis. If non-pharmacologi...
Osteoarthritis is a common cause of disability in the elderly. Management involves pharmacological a...
The paper presents the results of the Osteoarthritis (OA) Expert Council held on September 8, 2019, ...
Osteoarthritis (OA) is the most common pathology of the musculoskeletal system and is a serious medi...
Goal of osteoarthritis (OA) treatment is to relieve the pain and to reduce the loss of patient's phy...
Osteoarthritis (OA) is a leading cause of disability among older adults worldwide. Treatment aims ar...
Osteoarthritis is a chronic condition involving degeneration of cartilage within the joints. It is t...
Osteoarthritis (OA) is currently defined by the American College of Rheumatology as a "heterogeneous...
Osteoarthritis (OA) is currently defined by the American College of Rheumatology as a "heterogeneous...
Osteoarthritis (OA) is the most common form of joint disease and the leading cause of pain and physi...
Osteoarthritis is an arthritic condition of the joints commonly found in the elderly population. Thi...
Paracetamol is the first choice mediation for osteoarthritis. The analgetic potential of NSAIDs is s...
Osteoarthritis (OA) is a debilitative, painful condition with significant global burden. Pharmacolog...
Abstract: Current treatment guidelines for the treatment of chronic pain associated with osteoarthri...